- Home
- PANW vs BSX Comparison
PANW vs BSX Comparison
Compare PANW & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PANW
- BSX
- Stock Information
- Founded
- PANW 2005
- BSX 1979
- Country
- PANW United States
- BSX United States
- Employees
- PANW N/A
- BSX N/A
- Industry
- PANW Computer peripheral equipment
- BSX Medical/Dental Instruments
- Sector
- PANW Technology
- BSX Health Care
- Exchange
- PANW Nasdaq
- BSX Nasdaq
- Market Cap
- PANW 124.9B
- BSX 146.2B
- IPO Year
- PANW 2012
- BSX 1992
- Fundamental
- Price
- PANW $213.18
- BSX $98.90
- Analyst Decision
- PANW Buy
- BSX Strong Buy
- Analyst Count
- PANW 43
- BSX 19
- Target Price
- PANW $216.33
- BSX $124.53
- AVG Volume (30 Days)
- PANW 4.5M
- BSX 8.1M
- Earning Date
- PANW 11-19-2025
- BSX 10-22-2025
- Dividend Yield
- PANW N/A
- BSX N/A
- EPS Growth
- PANW N/A
- BSX 54.68
- EPS
- PANW 1.60
- BSX 1.87
- Revenue
- PANW $9,221,500,000.00
- BSX $19,349,000,000.00
- Revenue This Year
- PANW $16.29
- BSX $21.04
- Revenue Next Year
- PANW $13.43
- BSX $11.45
- P/E Ratio
- PANW $133.24
- BSX $52.89
- Revenue Growth
- PANW 14.87
- BSX 21.61
- 52 Week Low
- PANW $144.15
- BSX $84.13
- 52 Week High
- PANW $223.61
- BSX $109.50
- Technical
- Relative Strength Index (RSI)
- PANW 51.61
- BSX 46.76
- Support Level
- PANW $212.35
- BSX $98.06
- Resistance Level
- PANW $221.27
- BSX $102.27
- Average True Range (ATR)
- PANW 4.02
- BSX 1.86
- MACD
- PANW -0.72
- BSX -0.09
- Stochastic Oscillator
- PANW 47.82
- BSX 17.21
About PANW Palo Alto Networks Inc.
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three fourths of the Global 2000.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.